COST-EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN TAIWAN

被引：1
|
作者：
Zou, D. [1 ]
Kendall, R. [1 ]
Lin, Q. [2 ]
Huang, Y. [2 ]
Tieng, J. [3 ]
Tseng, J. [3 ]
Sajosi, P. [4 ]
机构：
[1] ICON Plc, Vancouver, BC, Canada
[2] Kantar Hlth, Taipei, Taiwan
[3] Takeda Pharmaceut Taiwan, Taipei, Taiwan
[4] Takeda Pharmaceut Int AG, Zurich, Switzerland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.08.705
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CE2
引用
收藏
页码：A811 / A811
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF USING BRENTUXIMAB VEDOTIN IN PATIENTS WITH RECURRENT HODGKIN LYMPHOMA OR REFRACTORY TO TRANSPLANT
    Romero Prada, M. E.
    Roa Cardenas, N. C.
    Vasquez Melo, E. C.
    Acero, G.
    Huerfano, L. M.
    de Los Rios de Acevedo, M.
    VALUE IN HEALTH, 2016, 19 (07) : A733 - A733
  • [42] Complete Response of Relapsed Systemic and Cutaneous Anaplastic Large Cell Lymphoma Using Brentuximab Vedotin: 2 Case Reports
    Broccoli, Alessandro
    Derenzini, Enrico
    Pellegrini, Cinzia
    Narducci, Riccardo
    Stefani, Giulia
    Casadei, Beatrice
    Argnani, Lisa
    Zinzani, Pier Luigi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 493 - 495
  • [43] Phase I Trial of Brentuximab Vedotin for Children with Recurrent or Refractory Hodgkin's Lymphoma or Systemic Anaplastic Large Cell Lymphoma
    Sekimizu, Masahiro
    Koga, Yuki
    Iguchi, Akihiro
    Mori, Tetsuya
    Asada, Ryuta
    Kada, Akiko
    Saito, Akiko
    Horibe, Keizo
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S11 - S12
  • [44] Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma
    Broccoli, Alessandro
    Pellegrini, Cinzia
    Di Rocco, Alice
    Puccini, Benedetta
    Patti, Caterina
    Gini, Guido
    Mannina, Donato
    Tani, Monica
    Rusconi, Chiara
    Romano, Alessandra
    Vanazzi, Anna
    Botto, Barbara
    Carlo-Stella, Carmelo
    Hohaus, Stefan
    Musto, Pellegrino
    Mazza, Patrizio
    Molica, Stefano
    Corradini, Paolo
    Fama, Angelo
    Gaudio, Francesco
    Merli, Michele
    Gravetti, Angela
    Gritti, Giuseppe
    Arcari, Annalisa
    Tosi, Patrizia
    Liberati, Anna Marina
    Pinto, Antonello
    Pavone, Vincenzo
    Gherlinzoni, Filippo
    Naso, Virginia
    Volpetti, Stefano
    Trentin, Livio
    Goldaniga, Maria Cecilia
    Bonfichi, Maurizio
    De Renzo, Amalia
    Schiavotto, Corrado
    Spina, Michele
    Storti, Sergio
    Carella, Angelo Michele
    Stefoni, Vittorio
    Argnani, Lisa
    Zinzani, Pier Luigi
    HAEMATOLOGICA, 2017, 102 (11) : 1931 - 1935
  • [45] Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan
    Tien, Feng-Ming
    Tsai, Cheng-Hong
    Liu, Jia-Hau
    Lin, Chien-Ting
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (10) : 1466 - 1470
  • [46] Brentuximab vedotin use in pediatric anaplastic large cell lymphoma
    Agrusa, Jennifer E.
    Egress, Emily R.
    Lowe, Eric J.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Brentuximab Vedotin and Crizotinib in Anaplastic Large-Cell Lymphoma
    Foyil, Kelley V.
    Bartlett, Nancy L.
    CANCER JOURNAL, 2012, 18 (05): : 450 - 456
  • [48] Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma (vol 130, pg 2709, 2017)
    Pro, B.
    Advani, R.
    Brice, P.
    BLOOD, 2018, 132 (04) : 458 - 459
  • [49] Long-Term Remissions Observed in an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
    Pro, Barbara
    Advani, Ranjana H.
    Brice, Pauline
    Bartlett, Nancy L.
    Rosenblatt, Joseph D.
    Illidge, Tim
    Matous, Jeffrey V.
    Ramchandren, Radhakrishnan
    Fanale, Michelle A.
    Connors, Joseph M.
    Yang, Yin
    Kennedy, Dana A.
    Shustov, Andrei R.
    BLOOD, 2012, 120 (21)
  • [50] Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma
    Pellegrini, Cinzia
    Rigacci, Luigi
    Patti, Caterina
    Gini, Guido
    Mannina, Donato
    Tani, Monica
    Rusconi, Chiara
    Romano, Alessandra
    Vanazzi, Anna
    Botto, Barbara
    Carlo-Stella, Carmelo
    Hohaus, Stefan
    Rigolin, Gian Matteo
    Musto, Pellegrino
    Mazza, Patrizio
    Molica, Stefano
    Corradini, Paolo
    Fama, Angelo
    Gaudio, Francesco
    Merli, Michele
    Gravetti, Angela
    Gritti, Giuseppe
    Arcari, Annalisa
    Tosi, Patrizia
    Liberati, Anna Marina
    Pinto, Antonello
    Pavone, Vincenzo
    Gherlinzoni, Filippo
    Naso, Virginia
    Volpetti, Stefano
    Visentin, Andrea
    Goldaniga, Maria Cecilia
    Bonfichi, Maurizio
    De Renzo, Amalia
    Schiavotto, Corrado
    Spina, Michele
    Storti, Sergio
    Carella, Angelo Michele
    Argnani, Lisa
    Zinzani, Pier Luigi
    BLOOD, 2016, 128 (22)
12345